Balwierz Walentyna, Moryl-Bujakowska Angelina, Balwierz Adriana, Pawińska Katarzyna
Klinika Onkologii i Hematologii, Polsko-Amerykańskiego Instytutu Pediatrii, Collegium Medicum, Uniwersytetu Jagiellohrskiego w Krakowie.
Przegl Lek. 2006;63(1):1-6.
Neutropenia is the most often side effect during antineoplastic treatment. In this article current recommendations for clinical applications of granulocyte and granulocyto-macrophage hematopoietic factors and possibility of protection of neutropenia, and its serious complications in pediatric oncology are presented.
中性粒细胞减少是抗肿瘤治疗中最常见的副作用。本文介绍了粒细胞和粒-巨噬细胞造血因子在临床应用中的当前建议，以及小儿肿瘤学中中性粒细胞减少症的预防及其严重并发症的可能性。
